Medicinal Products

Sitagliptin/metforminklorid Grindeks 50 mg/850 mg filmom obložene tablete

Name Sitagliptin/metforminklorid Grindeks 50 mg/850 mg filmom obložene tablete
Marketing Authorisation Number HR-H-589955694
Active Substance sitagliptinklorid hidrat
metforminklorid
Composition svaka filmom obložena tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina i 850 mg metforminklorida
Pharmaceutical Form Filmom obložena tableta
Manufacturer Grindeks AS, Riga, Latvija
Marketing Authorisation Holder AS Grindeks, Krustpils iela 53, Riga, Latvija
Marketing Authorisation Date 04.02.2022
MA Period of Validity 04.02.2027
MA Revocation Date 25.09.2026*
Classification Number UP/I-530-09/20-01/258
Registration Number 381-12-01/154-22-04
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product on medical prescription for renewable delivery
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code A10BD07
Marketing status Never marketed
SmPC download
PL download
Public Assessment Report download

*Note

Marketing authorisation has been revoked by request of the marketing authorisation holder. In accordance with Article 113 of Medicinal Products Act, only a medicinal product in respect of which a marketing authorisation has been granted by the Agency for Medicinal Products and Medical Devices or the European Commision, and a medicinal product in respect of which an authorisation for parallel import or parallel distribution has been granted may be placed on the market of the Republic of Croatia. By way of derogation from this provision, a batch of medicinal product may be on the market for no longer than 18 months following the expiry of revocation of the marketing authorisation, unless its shelf life expires first.

Packaging

Back